前列腺素 E2作用机制 - Medchemexpress - MCE中国_第1页
前列腺素 E2作用机制 - Medchemexpress - MCE中国_第2页
前列腺素 E2作用机制 - Medchemexpress - MCE中国_第3页
全文预览已结束

前列腺素 E2作用机制 - Medchemexpress - MCE中国.docx 免费下载

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Product Data SheetProstaglandin E2Cat. No.: HY-101952CAS No.: 363-24-6分式: CHO分量: 352.47作靶点: Prostaglandin Receptor; Endogenous Metabolite作通路: GPCR/G Protein; Metabolic Enzyme/Protease储存式: Powder -20C 3 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 100 mg/mL (283.71 mM)* means soluble, bu

2、t saturation unknown.SolventMass1 mg 5 mg 10 mgConcentration制备储备液1 mM 2.8371 mL 14.1856 mL 28.3712 mL5 mM 0.5674 mL 2.8371 mL 5.6742 mL10 mM 0.2837 mL 1.4186 mL 2.8371 mL请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;旦配成溶液,请分装保存,避免反复冻融造成的产品失效。储备液的保存式和期限:-80C, 6 months; -20C, 1 month。-80C 储存时,请在 6 个内使,-20C 储存时,请在 1 个内使

3、。体内实验请根据您的实验动物和给药式选择适当的溶解案。以下溶解案都请先按照 In Vitro 式配制澄清的储备液,再依次添加助溶剂:为保证实验结果的可靠性,澄 的储备液可以根据储存条件,适当保存;体内实验的作液,建议您现现配,当天使; 以下溶剂前显的百分 指该溶剂在您配制终溶液中的体积占;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的式助溶1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (7.09 mM); Clear solution此案可获得 2.5 mg/mL (7.0

4、9 mM,饱和度未知) 的澄清溶液。以 1 mL 作液为例,取 100 L 25.0 mg/mL 的澄 DMSO 储备液加到 400 L PEG300 中,混合均匀;向上述体系中加50 L Tween-80,混合均匀;然后继续加 450 L 理盐定容 1 mL。2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (7.09 mM); Clear solution此案可获得 2.5 mg/mL (7.09 mM,饱和度未知) 的澄清溶液。Page 1 of 2 www.MedChemE以 1 mL 作液为例

5、,取 100 L 25.0 mg/mL 的澄均匀。DMSO 储备液加到 900 L 20% 的 SBE-CD 理盐溶液中,混合BIOLOGICAL ACTIVITY物活性 Prostaglandin E2和炎症的调节。种激素样物质,参与泛的体功能,如平滑肌的收缩和松弛,管的扩张和收缩,压的控制IC & Target EP2 Receptor Human Endogenous Metabolite体外研究 PGE2 shows inhibition of IL 2 production in the mixture of irradiated and nonirradiated T lympho

6、cytes. PGE2 (0.1-10 M) dose-dependently inhibits the production of IL 2. PGE2 acts during the inductive phase of activation of suppressorcells. Preincubation of T lymphocytes with PGE2 induces cells that suppress IL 2 production and PHA proliferation1.体内研究 PGE2 (0.3 g/k, i.p.) significantly reduces

7、the number of peritoneab macrophages undergoing phagocytosis of themethacrybate microbeads in rats2. PGE2 (0.1 mg/min, i.a.) increases renal blood flow. PGE2 produces a biphasic change in renal vascular resistance, vasodilatation starts at 0.01 mg/min and is maximal at about 3 mg/min, while atthe hi

8、ghest dose used (20 mg/min) PGE2 induces renal vasoconstriction3.PROTOCOLCell Assay 1 Lymphocytes in CM (1106 cells/mL) are ditributed in microculture plates (100 L) in triplicate in the presence ofPGE-treated T cells or medium-treated T cells and stimulated with PHA-P at various mitogenic doses. Af

9、ter 72 hr,cultures are pulsed with 1 Ci 3Hthymidine per well (specific activity 5 Ci/mM) for 16 to 18 hr, collected withamicroprecipltator, dried, and counted in a liquid scintillation counter.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Male

10、Sprague Dawley rats (200-250 g) are used throughout the study. For 3 consecutive days rats in the experimentalAdministration 2 groups receive a daily intraperitoneal injection of either PGE2 (0.3 g/kg body weight (BW), the prostaglandininhibitor mecbofenamate (10 mg/kg BW) or the prostaglandin precu

11、rsor arachidonic acid (0.3 g/ kg BW). Todetermine whether or not 0.3 g/kg BW of a fatty acid produces nonspecific effects, the biologically inactive fattyacid 11, 14, 17-eicosatrienoic acid is also administered to a group of rats. Rats in the control group receive anequivalent volume (2.0 mL/kg BW)

12、of the vehicle. On the third day, 3 mL of a suspension containing 1.2106fluorescent methacrylate microbeads/mL of PBS are injected intraperitoneally (ip) into each rat. Six hours later allanimals are given ip a regular dose of their respective treatment. Peritoneal exudate cells are harvested 19-22

13、hrlater.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 Front Microbiol. 20 May 2020. J Cell Commun Signal. 2020 Jan 10. J Pediatr Surg. 2019 Feb 24. pii: S0022-3468(19)30008-9.See more customer validations on HYPERLINK www.MedChemE www.MedC

14、hemEPage 2 of 3 www.MedChemEREFERENCES1. Chouaib S, et al. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol. 1984Apr;132(4):1851-7.2. Fernandez-Repollet E, et al. In vivo effects of prostaglandin E2 and arachidonic acid on phagocytosis of fluorescent methacrylate microbeads by ratperitoneal macrophages. J Histochem Cytochem. 1982 May;30(5):466-70.3. Haylor J, et al. Renal vasodilator activity of prostaglandin E2 in the rat anaesthetized with pentobarbitone. Br J Pharmacol. 1982 May;76(1):131-7

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论